Nippon ShinyakuNippon Shinyaku Co.,Ltd.4516東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Nippon Shinyaku brought in ¥148.3B in revenue.
Revenue changed +2.8% from the prior year.
FY ending Mar 2023 → FY ending Mar 2024
FY ending Mar 2023 → FY ending Mar 2024
※ Cost of revenue is not disclosed; expenses are combined
※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains
A machine-readable operating income value exists, but it is not in the validated published data, so the chart is omitted.
EDINET (FSA Japan)
有価証券報告書－第163期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第161期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第159期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
訂正有価証券報告書－第158期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.